文献速递鼻科咽喉与嗓音

早期与延迟鼻窦手术治疗慢性鼻窦炎伴鼻息肉的哮喘结局对比

Asthma Outcomes Following Early Versus Delayed Sinus Surgery in Chronic Rhinosinusitis With Nasal Polyps.
PubMed 文献 · Int Forum Allergy Rhinol · 2025-12-30

本研究基于TriNetX回顾性队列,纳入接受内镜鼻窦手术的慢性鼻窦炎伴鼻息肉成人患者,比较早期手术(诊断后≤6个月)与延迟手术(1-3年)对5年哮喘结局的影响。经倾向性评分1:1匹配后,早期手术与较低的中重度持续性哮喘风险、较少的哮喘急性发作及较少的LABA、激素和生物制剂使用相关。

要点

  • 早期手术组中度持续性哮喘风险11.5% vs 13.5%,OR=0.84,p=0.012。
  • 早期手术组重度持续性哮喘风险6.5% vs 8.4%,OR=0.76,p=0.003。
  • 早期手术组哮喘急性发作6.4% vs 8.1%,OR=0.78,p=0.005。

核心结论

  • 早期内镜鼻窦手术与CRSwNP患者向中重度哮喘进展减少、急性发作减少及口服激素、LABA和生物制剂依赖降低相关。

研究设计与样本

  • 回顾性队列研究,使用TriNetX研究网络,纳入接受内镜鼻窦手术的成人CRSwNP患者。
  • 按诊断后手术时间分组:早期手术(≤6个月)或延迟手术(1-3年)。
  • 经倾向性评分1:1匹配后每组N=3683,匹配因素包括人口学、基线哮喘严重度和哮喘用药。

主要发现

  • 早期手术组中度持续性哮喘发生率11.5% vs 13.5%,OR=0.84,p=0.012。
  • 早期手术组重度持续性哮喘发生率6.5% vs 8.4%,OR=0.76,p=0.003。
  • 早期手术组哮喘急性发作率6.4% vs 8.1%,OR=0.78,p=0.005。
  • 早期手术组LABA使用率23.7% vs 29.4%,OR=0.75,p<0.0001。
  • 早期手术组激素使用率63.7% vs 67.4%,OR=0.85,p=0.0009;生物制剂使用率7.7% vs 10.1%,OR=0.74,p=0.0004。

关键数值与推荐

  • 早期手术定义为诊断后≤6个月行内镜鼻窦手术,延迟手术定义为诊断后1-3年。
  • 轻度间歇或持续性哮喘发生率及总体新发哮喘诊断在两组间无差异。

临床怎么用

  • 对于CRSwNP合并哮喘患者,早期内镜鼻窦手术可能有助于降低哮喘进展风险及减少哮喘相关用药负担。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic rhinosinusitis with nasal polyps (CRSwNP) often coexists with asthma. Endoscopic sinus surgery (ESS) improves asthma morbidity, but the impact of early surgery (< 6 months from diagnosis) versus later surgery (1-3 years) is unclear. We examined whether early ESS is associated with improved asthma outcomes compared with delayed surgery. METHODS: We conducted a retrospective cohort study using the TriNetX Research Network, including adults with CRSwNP who underwent ESS. Patients were grouped as early surgery (≤ 6 months after diagnosis) or late surgery (1-3 years). Outcomes over 5 years included asthma diagnoses by severity, exacerbations, and medication use (long-acting β2-agonists [LABA], corticosteroids, biologics). Propensity score matching was performed 1:1 (N = 3683 per group) based on demographics, baseline asthma severity, and asthma medication usage. RESULTS: After matching, groups were well balanced. Early ESS was associated with lower risk of moderate (11.5% vs. 13.5%; odds ratio [OR] = 0.84; p = 0.012) and severe persistent asthma (6.5% vs. 8.4%; OR = 0.76; p = 0.003). Rates of mild intermittent or persistent asthma and overall new asthma diagnoses did not differ. Early surgery patients had fewer associated asthma exacerbations (6.4% vs. 8.1%; OR = 0.78; p = 0.005) and were less likely to require LABAs (23.7% vs. 29.4%; OR = 0.75; p < 0.0001), steroids (63.7% vs. 67.4%; OR = 0.85; p = 0.0009), and biologics (7.7% vs. 10.1%; OR = 0.74; p = 0.0004). CONCLUSION: Early ESS for CRSwNP is associated with reduced progression to moderate/severe asthma, fewer exacerbations, and lower reliance on oral steroids, LABAs, and biologics. These findings suggest early surgery may alter asthma trajectory and reduce treatment burden in CRSwNP patients.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Oliver JR, Crafton CL, Attwood EW, et al. Asthma Outcomes Following Early Versus Delayed Sinus Surgery in Chronic Rhinosinusitis With Nasal Polyps. Int Forum Allergy Rhinol. 2025. PMID: 41467308. doi:10.1002/alr.70091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。